Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 7.03% is in line with its 5-year average of 7.46%, around the middle of its 5-year range (2.87%–11.86%).
45.55% above its 12-month average of 4.83%.
Reported quarterly return on assets; no daily interpolation. Q4 FY2026 (2026-06-30): 2.11%.
RETURN ON ASSETS (ROA)
7.03%
RETURN ON ASSETS (ROA) AVG TTM
4.83%
RETURN ON ASSETS (ROA) AVG 3Y
6.67%
RETURN ON ASSETS (ROA) AVG 5Y
7.46%
RETURN ON ASSETS (ROA) AVG 10Y
7.57%
RETURN ON ASSETS (ROA) AVG 15Y
9.66%
RETURN ON ASSETS (ROA) AVG 20Y
12.23%
CURRENT VS TTM AVG
+45.55%
CURRENT VS 3Y AVG
+5.36%
CURRENT VS 5Y AVG
-5.74%
CURRENT VS 10Y AVG
-7.10%
CURRENT VS 15Y AVG
-27.20%
CURRENT VS 20Y AVG
-42.53%
SECTOR MEDIAN · HEALTHCARE
5.14%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+36.77%
vs the sector median at left
Bio-Techne Corporation
Market Cap
$11.37B
Return on Assets (ROA)
7.03%
TTM Avg
4.83%
3Y Avg
6.67%
5Y Avg
7.46%
Market Cap
$10.83B
Return on Assets (ROA)
9.58%
TTM Avg
8.61%
3Y Avg
6.84%
5Y Avg
6.99%
Market Cap
$10.80B
Return on Assets (ROA)
4.50%
TTM Avg
3.10%
3Y Avg
3.02%
5Y Avg
7.71%
Market Cap
$12.08B
Return on Assets (ROA)
-5.37%
TTM Avg
-3.64%
3Y Avg
-1.62%
5Y Avg
0.47%
Market Cap
$10.51B
Return on Assets (ROA)
6.44%
TTM Avg
6.68%
3Y Avg
6.69%
5Y Avg
12.75%
Market Cap
$12.25B
Return on Assets (ROA)
8.33%
TTM Avg
7.48%
3Y Avg
6.38%
5Y Avg
5.99%
Market Cap
$10.26B
Return on Assets (ROA)
2.17%
TTM Avg
-6.26%
3Y Avg
-11.14%
5Y Avg
1.46%
Market Cap
$10.21B
Return on Assets (ROA)
6.59%
TTM Avg
6.34%
3Y Avg
6.05%
5Y Avg
6.29%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bio-Techne Corporation (TECH) | $11.37B | 7.03% | 4.83% | 6.67% | 7.46% |
| DaVita Inc. (DVA)vs › | $11.46B | 4.79% | 4.84% | 4.27% | 4.56% |
| Universal Health Services, Inc. (UHS)vs › | $10.83B | 9.58% | 8.61% | 6.84% | 6.99% |
| The Cooper Companies, Inc. (COO)vs › | $10.80B | 4.50% | 3.10% | 3.02% | 7.71% |
| Baxter International Inc. (BAX)vs › | $12.08B | -5.37% | -3.64% | -1.62% | 0.47% |
| Align Technology, Inc. (ALGN)vs › | $10.51B | 6.44% | 6.68% | 6.69% | 12.75% |
| Encompass Health Corporation (EHC)vs › | $12.25B | 8.33% | 7.48% | 6.38% | 5.99% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $10.26B | 2.17% | -6.26% | -11.14% | 1.46% |
| The Ensign Group, Inc. (ENSG)vs › | $10.21B | 6.59% | 6.34% | 6.05% | 6.29% |
| Penumbra, Inc. (PEN)vs › | $12.56B | 8.13% | 5.32% | 4.08% | 2.47% |
ROA
7.0%
ROE
8.6%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2026-06-30 | 6.79% |
| 2025-06-30 | 2.87% |
| 2024-06-30 | 6.22% |
| 2023-06-30 | 10.81% |
| 2022-06-30 | 11.86% |
| 2021-06-30 | 6.20% |
| 2020-06-30 | 11.31% |
| 2019-06-30 | 5.10% |
| 2018-06-30 | 7.87% |
| 2017-06-30 | 4.96% |
| 2016-06-30 | 9.25% |
| 2015-06-30 | 10.13% |
| 2014-06-30 | 12.86% |
| 2013-06-30 | 14.47% |
| 2012-06-30 | 15.62% |
| 2011-06-30 | 18.18% |
| 2010-06-30 | 21.16% |
| 2009-06-30 | 22.30% |
| 2008-06-30 | 20.41% |
| 2007-06-30 | 18.71% |
| 2006-06-30 | 19.80% |
| 2005-06-30 | 22.40% |
| 2004-06-30 | 16.26% |
| 2003-06-30 | 17.24% |
| 2002-06-30 | 11.39% |
| 2001-06-30 | 15.80% |
| 2000-06-30 | 14.73% |
| 1999-06-30 | 13.49% |
| 1998-06-30 | 20.85% |
| 1997-06-30 | 20.22% |
